| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 07/23/2003 | CN1432001A 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 07/23/2003 | CN1115330C N-(4-carbamimido-phenyl)-phenylglycinamid derivatives |
| 07/22/2003 | US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 07/22/2003 | US6596773 Central nervous system disorders |
| 07/22/2003 | US6596772 Relates to trifluoromethyl sulfonyl and trifluoromethyl sulfonamido compounds and the physiologically acceptable salts and the prodrugs thereof. These compounds are expected to modulate the activity of protein tyrosine enzymes which are |
| 07/22/2003 | US6596752 Inhibitors of α4β1 mediated cell adhesion |
| 07/22/2003 | US6596743 Carbamic acid derivatives |
| 07/22/2003 | US6596716 2-propane-sulphonamide derivatives |
| 07/22/2003 | US6596445 Initiators for photopolymerization of radically polymerizable compounds |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057664A1 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 07/17/2003 | WO2003057198A1 Pharmaceutical formulations with modified release |
| 07/17/2003 | WO2003057169A2 4-dedimethylamino tetracycline compounds |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2002055496A8 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
| 07/17/2003 | US20030134874 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
| 07/17/2003 | US20030134840 Novel compounds |
| 07/17/2003 | US20030134802 Novel effectors of dipepetidyl peptidase IV |
| 07/17/2003 | CA2471752A1 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/16/2003 | EP1327630A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
| 07/16/2003 | EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/16/2003 | EP1326834A2 2-substituted heterocyclic compounds |
| 07/16/2003 | EP1326833A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/16/2003 | EP1326827A2 Insecticidal 1,8-naphthalenedicarboxamides |
| 07/16/2003 | EP1326824A1 Pharmaceutical compounds |
| 07/16/2003 | EP1210353B1 Calcium complex of phosphorus containing ethylenediamine derivatives |
| 07/16/2003 | CN1430597A Novel MMP-2/MMP-9 inhibitors |
| 07/16/2003 | CN1114596C Biphenyl derivatives |
| 07/16/2003 | CN1114594C D4 receptor selectivity piperazine derivatives |
| 07/16/2003 | CN1114591C Cyclic amide compounds |
| 07/15/2003 | US6593474 Adrenergic blocking agents |
| 07/15/2003 | US6593473 Evaporating form aqueous solution; solidification |
| 07/15/2003 | US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 07/15/2003 | US6593345 Naphthyl compounds, intermediates, compositions, and methods of use |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593312 Cyclic α-amino-γ-hydroxyamide compounds |
| 07/15/2003 | US6592884 Method of using alpha-keto enamine derivatives as ingredients and products incorporating same |
| 07/15/2003 | CA2238465C Triaromatic compounds, compositions containing them and uses |
| 07/10/2003 | WO2003055851A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| 07/10/2003 | WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS |
| 07/10/2003 | WO2003055848A2 Urea derivatives as vr1- antagonists |
| 07/10/2003 | WO2003055847A1 Carboxylic acid derivative |
| 07/10/2003 | WO2003055492A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 |
| 07/10/2003 | WO2003055479A1 Compounds and their therapeutic use related to the phosphorylating activity of the enzyme gsk-3 |
| 07/10/2003 | WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 07/10/2003 | US20030130509 Process to produce 3-carbon amino alcohol salts |
| 07/10/2003 | US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion |
| 07/10/2003 | US20030130339 Such as (E)-2-pyridineethenyl-4-fluorobenzyl sulfone; antitumor/anticancer agents |
| 07/10/2003 | US20030130320 Alpha 4 integrin antagonists |
| 07/10/2003 | US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders |
| 07/10/2003 | US20030130272 Topoisomerase inhibitor; viricides |
| 07/10/2003 | US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/10/2003 | US20030130165 Method for treating neurodegenerative disorders |
| 07/10/2003 | US20030129591 Linker arms for nanocrystals and compounds thereof |
| 07/10/2003 | US20030129590 Linker arms for nanocrystals and compounds thereof |
| 07/10/2003 | CA2482392A1 Carboxylic acid derivative |
| 07/10/2003 | CA2469967A1 Urea derivatives as vr1- antagonists |
| 07/09/2003 | EP1325912A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
| 07/09/2003 | EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 07/09/2003 | EP1324970A2 Retinoids for the treatment of emphysema |
| 07/09/2003 | CN1429229A Hydroxylamine esters as polymerization initiators |
| 07/09/2003 | CN1429216A A new process for synthesis of morpholinylbenzenes |
| 07/09/2003 | CN1429210A Substituted thioacetamides |
| 07/09/2003 | CN1429199A Insecticidal 1,8-naphthalenedicarboxamides |
| 07/09/2003 | CN1429133A Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 07/09/2003 | CN1429107A Compositions cotaining benzamide disulfide derivative for treating allergic diseases |
| 07/09/2003 | CN1113876C Preparation of N-formyl morpholine, N-formyl piperazine and their homologues |
| 07/09/2003 | CN1113866C Process for preparation of piperidines |
| 07/09/2003 | CN1113855C Preparation of alkylamines |
| 07/08/2003 | CA2290501C Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
| 07/03/2003 | WO2003053942A1 Aryloxyphenyl and arylsulfanylphenyl derivatives |
| 07/03/2003 | WO2003053927A1 Piperazine derivative |
| 07/03/2003 | WO2003053919A1 Substituted cyclohexane derivatives |
| 07/03/2003 | WO2003053918A2 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 07/03/2003 | WO2003053915A2 Compounds for the treatment of inflammatory disorders |
| 07/03/2003 | WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS |
| 07/03/2003 | WO2003053885A1 Method for forming a carbon-carbon or carbon-heteroatom linkage |
| 07/03/2003 | US20030125558 5-bromosalicylaldehyde is reacted in a one-pot reaction firstly with haloaceticalkyl or benzylester and then with formamide to give 5-L-benzofuran-2-carboxamide, then transition metal-catalyzed ammination with piperazines |
| 07/03/2003 | US20030125557 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/03/2003 | US20030125549 Process for the catalytic asymmetric disubstitution of carboxamides using 2 different Grignard reagents |
| 07/03/2003 | US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/03/2003 | US20030125348 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide |
| 07/03/2003 | US20030125329 Treating atherosclerosis and other coronary artery diseases |
| 07/03/2003 | US20030125328 Treating atherosclerosis and other coronary artery diseases |
| 07/03/2003 | US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 07/03/2003 | CA2471038A1 Process for the preparation of perfluoroalkanesulfonic acid esters and salts thereof |
| 07/03/2003 | CA2470808A1 Piperazine derivative |
| 07/03/2003 | CA2470141A1 Method for forming a carbon-carbon or carbon-heteroatom linkage |
| 07/03/2003 | CA2467118A1 Aryloxyphenyl and arylsulfanylphenyl derivatives |
| 07/02/2003 | EP1322610A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa |
| 07/02/2003 | EP1322602A1 Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and to a medicament containing these compounds |
| 07/02/2003 | EP1322590A1 5-amino-1-pentene-3-ol substituted derivatives |
| 07/02/2003 | EP1322331A2 Fatty acid synthase inhibitors |
| 07/02/2003 | EP0973780B1 Antibacterial substituted 7-acylamino -3-(methylhydrazono) methyl-cephalosporins and intermediates |
| 07/02/2003 | EP0944582B1 Ketobenzamides as calpain inhibitors |
| 07/02/2003 | CN1427829A Substituted phenylacetamides and their use as glucokinase activators |
| 07/02/2003 | CN1427816A Process for forming amide bond |
| 07/02/2003 | CN1427809A Nitroaromatic solubilizer for nitroxyls in aromatic solvents |